51
|
Blum K, Abramson J, Maris M, Flinn I, Goy A, Mertz J, Sims R, Garner F, Senderowicz A, Younes A. A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy048] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
52
|
Batlevi CL, Younes A. Revival of PI3K inhibitors in non-Hodgkin's lymphoma. Ann Oncol 2018; 28:2047-2049. [PMID: 28911078 DOI: 10.1093/annonc/mdx392] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
|
53
|
Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol 2017; 28:1436-1447. [PMID: 28379322 PMCID: PMC5834038 DOI: 10.1093/annonc/mdx097] [Citation(s) in RCA: 200] [Impact Index Per Article: 28.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2017] [Indexed: 12/20/2022] Open
Abstract
In recent years, the number of approved and investigational agents that can be safely administered for the treatment of lymphoma patients for a prolonged period of time has substantially increased. Many of these novel agents are evaluated in early-phase clinical trials in patients with a wide range of malignancies, including solid tumors and lymphoma. Furthermore, with the advances in genome sequencing, new "basket" clinical trial designs have emerged that select patients based on the presence of specific genetic alterations across different types of solid tumors and lymphoma. The standard response criteria currently in use for lymphoma are the Lugano Criteria which are based on [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography or bidimensional tumor measurements on computerized tomography scans. These differ from the RECIST criteria used in solid tumors, which use unidimensional measurements. The RECIL group hypothesized that single-dimension measurement could be used to assess response to therapy in lymphoma patients, producing results similar to the standard criteria. We tested this hypothesis by analyzing 47 828 imaging measurements from 2983 individual adult and pediatric lymphoma patients enrolled on 10 multicenter clinical trials and developed new lymphoma response criteria (RECIL 2017). We demonstrate that assessment of tumor burden in lymphoma clinical trials can use the sum of longest diameters of a maximum of three target lesions. Furthermore, we introduced a new provisional category of a minor response. We also clarified response assessment in patients receiving novel immune therapy and targeted agents that generate unique imaging situations.
Collapse
|
54
|
Batlevi C, Alperovich A, Ni A, Soumerai J, Smith K, Ying Z, Caron P, Drullinsky P, Gerecitano J, Hamilton A, Hamlin P, Horwitz S, Kumar A, Matasar M, Moskowitz A, Moskowitz C, Noy A, Palomba M, Portlock C, Sauter C, Straus D, Zelenetz A, Seshan V, Younes A. DEFINING PROGRESSION FREE SURVIVAL AFTER MULTIPLE LINES OF THERAPY AND IMPACT OF DYNAMIC CHANGES IN FLIPI FOR MULTIPLY RELAPSED FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_92] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
55
|
Batlevi C, Hamlin P, Matasar M, Gerecitano J, Drullinsky P, Hamilton A, Straus D, Horwitz S, Kumar A, Moskowitz C, Moskowitz A, Zelenetz A, Ahsanuddin S, Callan D, Freidin B, Porzio R, Soiffer J, Copeland A, Dang T, Rademaker J, Schoder H, Ni A, Younes A. PHASE I/IB DOSE ESCALATION AND EXPANSION OF IBRUTINIB AND BUPARLISIB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, MANTLE CELL LYMPHOMA, AND FOLLICULAR LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_38] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
56
|
Fanale M, Engert A, Younes A, Armand P, Ansell S, Zinzani P, Timmerman J, Collins G, Ramchandren R, Cohen J, De Boer J, Kuruvilla J, Savage K, Trneny M, Rodig S, Shipp M, Kato K, Sumbul A, Farsaci B, Santoro A. NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW-UP OF THE PHASE 2 CHECKMATE 205 TRIAL. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_124] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
57
|
Moskowitz A, Schöder H, Gavane S, Thoren K, Fleisher M, Yahalom J, McCall S, Fox S, Gerecitano J, Grewal R, Hamlin P, Horwitz S, Kumar A, Matasar M, Ni A, Noy A, Palomba M, Perales M, Portlock C, Sauter C, Straus D, Younes A, Zelenetz A, Moskowitz C. BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET-ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_17] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
58
|
Soumerai J, Ni A, Batlevi C, Alperovich A, Bantilan K, Palomba M, Gerecitano J, Noy A, Hamlin P, Moskowitz C, Copeland A, Matasar M, Drullinsky P, Hamilton A, Horwitz S, Intlekofer A, Kumar A, Moskowitz A, Portlock C, Sauter C, Straus D, Caron P, Ying Z, Smith K, Younes A, Zelenetz A. TIME FROM DIAGNOSIS TO 2ND TREATMENT IS A PROMISING SURROGATE FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_93] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
59
|
Sauter C, Matasar M, Schoder H, Drullinsky P, Gerecitano J, Kumar A, Noy A, Palomba M, Portlock C, Straus D, Zelenetz A, McCall S, Miller S, Courtien A, Younes A, Moskowitz C. A PHASE I STUDY OF IBRUTINIB COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
60
|
Kumar A, Casulo C, Advani R, Budde E, Barr P, Batlevi C, Chen R, Constine L, Courtien A, Dandapani S, Drullinsky P, Friedberg J, Hamlin P, Hoppe R, Matasar M, McArthur G, Miller S, Moskowitz A, Noy A, Schoder H, Straus D, Yang J, Younes A, Zelenetz A, Yahalom J, Moskowitz C. A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
61
|
Younes A, Alliot C, Mokili B, Deniaud D, Montavon G, Champion J. Solvent Extraction of Polonium(IV) with Tributylphosphate (TBP). SOLVENT EXTRACTION AND ION EXCHANGE 2017. [DOI: 10.1080/07366299.2017.1279917] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
62
|
Ahmed S, Hafez H, El Nadi E, Labib R, Younes A, Ahmed G, Zaghloul M, Taha H, El Haddad A. Effect of delaying local control radiotherapy on outcome of localized pediatric bladder/prostate rhabdomyosarcoma. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30555-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
63
|
Aupiais J, Younes A, Moisy P, Hennig C, Rossberg A, Brunel B, Kerbaa M, Vidaud C, Den Auwer C. Structural and thermodynamic investigation of AnIVLI(O)HOPO. NEW J CHEM 2017. [DOI: 10.1039/c7nj02123b] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
For the first time, capillary electrophoresis coupled with inductively coupled plasma mass spectrometry has been used to determine the stability constants of PuIV with the multidentate hydroxypyridinonate chelating agents LI(O)HOPO in 0.1 M NaNO3 solution, pcH = 1.395 at 25 °C through competition with the NTA ligand.
Collapse
|
64
|
Younes A, Montavon G, Gouin SG, André-Joyaux E, Peumery R, Chalopin T, Alliot C, Mokili M, Champion J, Deniaud D. Investigation of a new “N2S2O2” chelating agent with high Po(iv) affinity. Chem Commun (Camb) 2017; 53:6492-6495. [DOI: 10.1039/c7cc03198j] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A water-soluble complexing agent for 210-polonium decorporation was designed and synthesised with a high conditional stability constant.
Collapse
|
65
|
Younes A, Delay F, Fajraoui N, Fahs M, Mara TA. Global sensitivity analysis and Bayesian parameter inference for solute transport in porous media colonized by biofilms. JOURNAL OF CONTAMINANT HYDROLOGY 2016; 191:1-18. [PMID: 27182791 DOI: 10.1016/j.jconhyd.2016.04.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2015] [Revised: 03/22/2016] [Accepted: 04/30/2016] [Indexed: 06/05/2023]
Abstract
The concept of dual flowing continuum is a promising approach for modeling solute transport in porous media that includes biofilm phases. The highly dispersed transit time distributions often generated by these media are taken into consideration by simply stipulating that advection-dispersion transport occurs through both the porous and the biofilm phases. Both phases are coupled but assigned with contrasting hydrodynamic properties. However, the dual flowing continuum suffers from intrinsic equifinality in the sense that the outlet solute concentration can be the result of several parameter sets of the two flowing phases. To assess the applicability of the dual flowing continuum, we investigate how the model behaves with respect to its parameters. For the purpose of this study, a Global Sensitivity Analysis (GSA) and a Statistical Calibration (SC) of model parameters are performed for two transport scenarios that differ by the strength of interaction between the flowing phases. The GSA is shown to be a valuable tool to understand how the complex system behaves. The results indicate that the rate of mass transfer between the two phases is a key parameter of the model behavior and influences the identifiability of the other parameters. For weak mass exchanges, the output concentration is mainly controlled by the velocity in the porous medium and by the porosity of both flowing phases. In the case of large mass exchanges, the kinetics of this exchange also controls the output concentration. The SC results show that transport with large mass exchange between the flowing phases is more likely affected by equifinality than transport with weak exchange. The SC also indicates that weakly sensitive parameters, such as the dispersion in each phase, can be accurately identified. Removing them from calibration procedures is not recommended because it might result in biased estimations of the highly sensitive parameters.
Collapse
|
66
|
Stathis A, Younes A. The new therapeutical scenario of Hodgkin lymphoma. Ann Oncol 2015; 26:2026-33. [DOI: 10.1093/annonc/mdv256] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2015] [Accepted: 05/20/2015] [Indexed: 12/18/2022] Open
|
67
|
Elnadi E, Hafiz H, Elzomor H, Labib R, Alfaar A, Zaghloul M, Taha H, Younes A, Elwakel M. 1406 Childhood Orbital Rhabdomyosarcoma. Report from Children's Cancer Hospital-57357-Egypt. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(15)30021-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
68
|
Elnady M, Abd Elwahed R, Younes A. EFFECT OF RESTRICTED FEEDING AND PARTIAL WATER RENEWAL ON WATER QUALITY AND GROWTH PERFORMANCE OF NILE TILAPIA UNDER BIOFLOC CULTURE. EGYPTIAN JOURNAL OF AGRICULTURAL SCIENCES 2015; 66:223-233. [DOI: 10.21608/ejarc.2015.213352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
69
|
Younes A, Younes M, Sayah H, Samuila A, Dascalescu L. Experimental and Numerical Modeling of a New Tribo-Electrostatic Separation Process for Granular Plastics Mixtures. PARTICULATE SCIENCE AND TECHNOLOGY 2014. [DOI: 10.1080/02726351.2014.948976] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
70
|
Dabaja B, Shihadeh F, Rodriguez M, Etzel C, Liang F, Shirvani S, Ballas L, Allen P, Fanale M, Wogan C, Younes A, Oki Y. Improvements in Treatments for Hodgkin Lymphoma Over a 50-Year Period Lead to Fewer Second Malignancies. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
71
|
Oki Y, Buglio D, Zhang J, Ying Y, Zhou S, Sureda A, Ben-Yehuda D, Zinzani PL, Prince HM, Harrison SJ, Kirschbaum M, Johnston PB, Shen A, von Tresckow B, Younes A. Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression. Blood Cancer J 2014; 4:e236. [PMID: 25105535 PMCID: PMC4219471 DOI: 10.1038/bcj.2014.58] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
|
72
|
Derenzini E, Lemoine M, Buglio D, Katayama H, Ji Y, Davis RE, Sen S, Younes A. Erratum: The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. Blood Cancer J 2014. [PMCID: PMC4219443 DOI: 10.1038/bcj.2014.57] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
73
|
Younes A, Montavon G, Alliot C, Mokili M, Haddad F, Deniaud D, Champion J. A route for polonium 210 production from alpha-particle irradiated bismuth-209 target. RADIOCHIM ACTA 2014. [DOI: 10.1515/ract-2013-2171] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
A method is proposed for production of polonium-210 via the 209Bi(α, 3n)210At nuclear
reaction. Bombardment of a bismuth-209 target was performed with a 37 MeV alpha-particle beam that leads to the production
of astatine-210 (T
1/2 = 8.1 h), which decays to polonium-210. It is purified from the bismuth target matrix by employing
liquid–liquid extraction using tributyl phosphate (TBP) in para-xylene from 7 M hydrochloric acid. Back extraction
of polonium-210 was performed by 9 M nitric acid. This method allows to purify a tracer amount of Po-210
(2.6 · 10
–13 mol) from macroscopic amount of Bi (2.8 · 10
–2 mol).
Collapse
|
74
|
Younes A, Hamouda A, Amyes S. First Report of a Novel Extended-Spectrum Beta-Lactamase KOXY-2 ProducingKlebsiella oxytocathat Hydrolyses Cefotaxime and Ceftazidime. J Chemother 2013; 23:127-30. [DOI: 10.1179/joc.2011.23.3.127] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
75
|
Younes M, Younes A, Sayah H, Tilmatine A, Samuila A, Dascalescu L. Numerical and Experimental Study of Insulating Particles Behavior in Roll-Type Corona-Electrostatic Separators. PARTICULATE SCIENCE AND TECHNOLOGY 2013. [DOI: 10.1080/02726351.2011.648822] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|